M-protein >2 g/dL, clonal bone marrow plasma cells (PCs) >20%, and serum immunoglobulin free light chains (FLC) ratio >20; Progression to multiple myeloma (MM) is 23-82%, depending on the severity; Management is by observation until progression to MM. This evidence concerns the gene MYOM2 and plasma cell myeloma.